Annual Reports and Related Documents:: Annual Reports and Related Documents Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
NABOTA SUCCESSFULLY REGISTERED IN SINGAPORE General Announcement Filing viewer · member access Original SGX announcement
HYPHENS PHARMA LICENSES WINLEVI FOR ALL 10 ASEAN COUNTRIES FROM COSMO PHARMACEUTICALS General Announcement Filing viewer · member access Original SGX announcement
HYPHENS PHARMA'S MERADAN CREAM LAUNCHES IN INDONESIA General Announcement Filing viewer · member access Original SGX announcement
QUARTERLY BUSINESS UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2022 General Announcement Filing viewer · member access Original SGX announcement
Hyphens Pharma TDF Blu Voile Sunscreen General Announcement Filing viewer · member access Original SGX announcement
RESULTS BRIEFING 1H 2022 General Announcement Filing viewer · member access Original SGX announcement
Half Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
COMPLETION OF INVESTMENT IN DOCMED TECHNOLOGY General Announcement Filing viewer · member access Original SGX announcement
Annual Reports and Related Documents:: Annual Reports and Related Documents Filing viewer · member access Original SGX announcement
CORPORATE PRESENTATION - DOCMED General Announcement Filing viewer · member access Original SGX announcement
HYPHENS ATTRACTS S$6 MILLION INVESTMENT IN DOCMED TECHNOLOGY TO GROW DIGITAL HEALTHTECH General Announcement Filing viewer · member access Original SGX announcement
Resignation of Chief Financial Officer Change - Announcement of Cessation Filing viewer · member access Original SGX announcement
Annual Reports and Related Documents:: Annual Reports and Related Documents Filing viewer · member access Original SGX announcement
Full Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
HYPHENS PHARMA OFFICIALLY LAUNCHES WELLAWAY General Announcement Filing viewer · member access Original SGX announcement
HYPHENS PHARMA HAS INKED EXCLUSIVE LICENSING DEAL OF USTEKINUMAB BIOSIMILAR General Announcement Filing viewer · member access Original SGX announcement
